OFIX
Orthofix Medical Inc.
Next earnings Aug 3, 2026 · consensus $-0.42 EPS, $213M rev
Last earnings +3.6% on 2026-05-05
$9.78
▲ +5.05%$9.78▼ -5.37%
over 1Y
L $8.95EODHDH $16.23
Earnings Dividend Split Congress buy Congress sellGrouped by date · hover a pin to expand
Today+5.0%
1W+9.3%
1M+4.9%
3M-15.0%
YTD-34.1%
1Y-5.4%
Sell
Conviction
Horizon
Medium (3–12mo)
Street · 11 analysts
Buy
Conservative balance sheet (liabilities/equity 0.89x); but unprofitable (net margin -11.2%).
Orthofix Medical Inc. shows $822M in FY2025 revenue (+2.9% YoY), a -11.2% net margin, and -20.5% ROE.
Financials · annual, by fiscal year
| Line item | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Revenue | $464M | $461M | $747M | $799M | $822M |
| Gross profit | $350M | $337M | $486M | $546M | $566M |
| Operating income | -$8.31M | -$13.3M | -$139M | -$84.6M | -$81.4M |
| Net income | -$38.4M | -$19.7M | -$151M | -$126M | -$92.2M |
| Diluted EPS | -$1.95 | -$0.98 | -$4.12 | -$3.30 | -$2.33 |
| Net margin | -8.3% | -4.3% | -20.3% | -15.8% | -11.2% |
Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.
Key statistics
Valuation
Enterprise value$468M
EV / EBITDA—
EV / Sales0.6
EV / FCF—
P / FCF—
PEG (trailing)—
Earnings yield-23.5%
FCF yield-0.3%
Quality & risk
ROIC (est.)-10.6%
Free cash flow-$1.28M
Total debt$157M
Net cash-$75.4M
Altman Z-Score0.98 distress
Piotroski F-Score5/9
Capital returns
Buyback yield16.2%
Dividend yield (est.)—
Shareholder yield16.2%
Shares Δ YoY+2.9%
Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.
Disclosure timeline
SEC · 8-Ks + reportsSome governance/structural items recently, but no outright red flags.
Recent filings
all on EDGAR ↗4Period ending 2026-06-182026-06-22open ↗4Period ending 2026-06-102026-06-12open ↗4Period ending 2026-06-102026-06-12open ↗4Period ending 2026-06-102026-06-12open ↗4Period ending 2026-06-102026-06-12open ↗4Period ending 2026-06-102026-06-12open ↗4Period ending 2026-06-102026-06-12open ↗4Period ending 2026-06-102026-06-12open ↗4Period ending 2026-06-102026-06-12open ↗4Period ending 2026-06-102026-06-12open ↗8-KPeriod ending 2026-06-112026-06-11open ↗4Period ending 2026-05-222026-05-29open ↗
Frequently asked
- Is Orthofix Medical Inc. (OFIX) a buy?
- OFIX currently carries a Sell rating with 3/5 conviction, derived from its latest SEC filings. Conservative balance sheet (liabilities/equity 0.89x); but unprofitable (net margin -11.2%).
- What is Orthofix Medical Inc.'s quality score?
- OFIX scores 59.94117647058823/100 (grade C) on a SEC-grounded quality model spanning value, growth, profitability, financial health and momentum.
Sources: SEC EDGAR (CIK 0000884624, latest 10-Q filed 2026-05-05) · EODHD · as of 6/26/2026, 7:14:01 PM.
Research and education only — not financial advice. EDGAR is not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities EDGAR rates; see Disclosures. Past performance does not guarantee future results. Do your own research.